Fidelity D&D Bancorp’s CVS Health CVS Stock Holding History

Fidelity D&D Bancorp’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,198	Closed	-$255K	–	108
2024 Q1	$255K	Sell	3,198 -54	-2%	-$4.13K	0.19%	78
2023 Q4	$257K	Sell	3,252 -313	-9%	-$22.3K	0.2%	80
2023 Q3	$249K	Buy	+3,565	New	+$253K	0.26%	75
2023 Q1	$255K	Buy	+3,198	New	+$268K	0.19%	78

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity D&D Bancorp's CVS Position: Q2 2024 in Review

Fidelity D&D Bancorp sold out of CVS Health (CVS) in Q2 2024, closing a stake of 3,198 shares — an estimated $255K sold.

Fidelity D&D Bancorp first reported a position in CVS in Q1 2023 and held it in 4 quarters. The position peaked at $257K in Q4 2023. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

Fidelity D&D Bancorp reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
Fidelity D&D Bancorp sold 3,198 CVS Health shares in Q2 2024, an estimated $255K.
Fidelity D&D Bancorp first reported a position in CVS Health in Q1 2023 and held it in 4 quarters.
Fidelity D&D Bancorp's CVS Health position peaked at $257K in Q4 2023.
1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Fidelity D&D Bancorp's 13F filing for Q2 2024, filed 5 Aug 2024.